Arch Biopartners, Inc. (ARCH.V)
0.86
+0.03
(+3.61%)
CAD |
TSXV |
Oct 13, 16:00
Arch Biopartners Market Cap : 58.42M for Oct. 13, 2026
Market Cap Chart
Historical Market Cap Data
| Date | Value |
|---|---|
| October 13, 2026 | 58.42M |
| October 09, 2026 | 56.38M |
| October 08, 2026 | 57.06M |
| October 07, 2026 | 57.74M |
| October 06, 2026 | 58.42M |
| October 05, 2026 | 56.38M |
| October 02, 2026 | 56.38M |
| October 01, 2026 | 56.38M |
| September 30, 2026 | 60.46M |
| September 29, 2026 | 61.14M |
| September 28, 2026 | 57.74M |
| September 25, 2026 | 57.06M |
| September 24, 2026 | 58.42M |
| September 23, 2026 | 55.03M |
| September 22, 2026 | 57.06M |
| September 21, 2026 | 55.03M |
| September 18, 2026 | 58.42M |
| September 17, 2026 | 62.50M |
| September 16, 2026 | 61.82M |
| September 15, 2026 | 60.46M |
| September 14, 2026 | 63.18M |
| September 11, 2026 | 62.50M |
| September 10, 2026 | 61.82M |
| September 09, 2026 | 65.22M |
| September 08, 2026 | 65.22M |
| Date | Value |
|---|---|
| September 04, 2026 | 69.29M |
| September 03, 2026 | 73.37M |
| September 02, 2026 | 69.97M |
| September 01, 2026 | 68.61M |
| August 31, 2026 | 69.97M |
| August 28, 2026 | 74.05M |
| August 27, 2026 | 64.54M |
| August 26, 2026 | 69.76M |
| August 25, 2026 | 72.47M |
| August 24, 2026 | 78.56M |
| August 21, 2026 | 75.85M |
| August 20, 2026 | 68.40M |
| August 19, 2026 | 74.50M |
| August 18, 2026 | 77.89M |
| August 17, 2026 | 73.82M |
| August 14, 2026 | 75.18M |
| August 13, 2026 | 77.89M |
| August 12, 2026 | 74.50M |
| August 11, 2026 | 73.82M |
| August 10, 2026 | 79.24M |
| August 07, 2026 | 71.79M |
| August 06, 2026 | 61.63M |
| August 05, 2026 | 62.99M |
| August 04, 2026 | 56.89M |
| July 31, 2026 | 54.86M |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| Innovotech, Inc. | 3.538M |
| Kane Biotech, Inc. | 5.126M |
| Quest PharmaTech, Inc. | 3.383M |
| BriaCell Therapeutics Corp. | 38.50M |
| Vaxil Bio Ltd. | 0.5777M |
Market Cap Related Metrics
| PEG Ratio | -1.044 |
| Price | 0.86 |
| Earnings Yield | -4.94% |
| PEGY Ratio | -1.044 |